Condition: Vitreoretinal Surgery · Ocular Inflammation · Post-operative Pain · Sponsor: The Cleveland Clinic
This study will assess the control of inflammation at days 1, 7, 14, and 21 days following the vitreoretinal surgical procedure analyzing two randomized study arms: Intracanalicular dexamethasone insert group or topical steroid drop group. Patients must be 18 years of age and older, of any race and either sex, requiring surgery with the procedure type of pars plana vitrectomy for either the indication of macular hole, epiretinal membrane removal, or vitreomacular traction.
This description comes directly from the study's public registry record.
Katherine Talcott, M.D. · 440 988-4040 · talcotk@ccf.org
Angela Meador, MHA · 216-445-7176 · meadora@ccf.org
Always discuss trial participation with your own doctor first.
| Cole Eye Institute, Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04371445